12-111446804-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005475.3(SH2B3):āc.784T>Cā(p.Trp262Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.581 in 1,570,508 control chromosomes in the GnomAD database, including 282,793 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005475.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2B3 | NM_005475.3 | c.784T>C | p.Trp262Arg | missense_variant | 3/8 | ENST00000341259.7 | NP_005466.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH2B3 | ENST00000341259.7 | c.784T>C | p.Trp262Arg | missense_variant | 3/8 | 1 | NM_005475.3 | ENSP00000345492 | P1 | |
SH2B3 | ENST00000538307.1 | c.178T>C | p.Trp60Arg | missense_variant | 2/7 | 2 | ENSP00000440597 | |||
ATXN2 | ENST00000642389.2 | c.*171-2617A>G | intron_variant, NMD_transcript_variant | ENSP00000496055 |
Frequencies
GnomAD3 genomes AF: 0.676 AC: 102715AN: 151964Hom.: 37652 Cov.: 32
GnomAD3 exomes AF: 0.667 AC: 147137AN: 220466Hom.: 53297 AF XY: 0.661 AC XY: 77382AN XY: 117014
GnomAD4 exome AF: 0.571 AC: 809276AN: 1418426Hom.: 245066 Cov.: 36 AF XY: 0.577 AC XY: 403420AN XY: 699524
GnomAD4 genome AF: 0.676 AC: 102854AN: 152082Hom.: 37727 Cov.: 32 AF XY: 0.688 AC XY: 51173AN XY: 74348
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 10, 2019 | This variant is associated with the following publications: (PMID: 26553438, 28628107, 29547645, 21909115, 26621817, 18311140, 20546165, 23222517, 24777453, 19820697, 19198610, 17554260, 24026423, 24482502, 20560212) - |
Primary myelofibrosis;C3277671:Thrombocythemia 1;C4551637:Primary familial polycythemia due to EPO receptor mutation Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 16, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at